Chronic Sildenafil for Severe Diaphragmatic Hernia
- Conditions
- Hypertension, PulmonaryHypoplasia, PulmonaryHernia, Diaphragmatic
- Interventions
- Drug: Placebo
- First Posted Date
- 2005-08-23
- Last Posted Date
- 2021-01-13
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 9
- Registration Number
- NCT00133679
- Locations
- 🇺🇸
Children's Hospital of Los Angeles, Los Angeles, California, United States
🇺🇸University of California San Francisco Children's Hospital, San Francisco, California, United States
🇺🇸Children's Memorial Hospital, Chicago, Illinois, United States
Treatment of Latent TB Infection for Jailed Persons
- First Posted Date
- 2005-08-09
- Last Posted Date
- 2020-07-21
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 364
- Registration Number
- NCT00128206
- Locations
- 🇺🇸
University of California San Francisco, San Francisco, California, United States
Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2005-08-04
- Last Posted Date
- 2012-09-17
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 53
- Registration Number
- NCT00126633
- Locations
- 🇺🇸
UCSF Comprehensive Cancer Center, San Francisco, California, United States
Longitudinal Antimalarial Combinations in Uganda
- Conditions
- Malaria
- Interventions
- Drug: Artemether+LumefantrineDrug: Amodiaquine+ArtesunateDrug: Amodiaquine+Sulfadoxine/Pyrimethamine
- First Posted Date
- 2005-07-25
- Last Posted Date
- 2020-06-09
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 601
- Registration Number
- NCT00123552
- Locations
- 🇺🇬
Assessment Center - Mulago Hospital, Kampala, Uganda
Effectiveness of the Diaphragm for HIV Prevention
- Conditions
- HIV Infection
- First Posted Date
- 2005-07-21
- Last Posted Date
- 2015-03-04
- Lead Sponsor
- University of California, San Francisco
- Registration Number
- NCT00121459
- Locations
- 🇿🇦
Perinatal HIV Research Unit, Soweto, Gauteng, South Africa
🇿🇦Medical Research Council of South Africa, Durban, KwaZulu Natal, South Africa
🇿🇼UZ-UCSF, Harare, Zimbabwe
Activated Protein C to Treat Acute Lung Injuries
- Conditions
- Respiratory Distress Syndrome, Adult
- First Posted Date
- 2005-05-30
- Last Posted Date
- 2014-03-13
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 90
- Registration Number
- NCT00112164
- Locations
- 🇺🇸
Joseph M. Still Burn Center, Augusta, Georgia, United States
🇺🇸San Francisco General Hospital, San Francisco, California, United States
🇺🇸Yale School of Medicine, Section of Pulmonary & Critical Care Medicine, New Haven, Connecticut, United States
LGBT Internet Based Smoking Treatment - 1
- Conditions
- Tobacco Use Disorder
- Interventions
- Behavioral: Standard Web-based interventionBehavioral: Tobacco Use Disorder
- First Posted Date
- 2005-05-23
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 792
- Registration Number
- NCT00111501
- Locations
- 🇺🇸
University of California San Francisco Medical Cen, San Francisco, California, United States
Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2005-02-08
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- University of California, San Francisco
- Registration Number
- NCT00103155
- Locations
- 🇺🇸
UCSF Comprehensive Cancer Center, San Francisco, California, United States
Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2004-12-09
- Last Posted Date
- 2014-01-06
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 25
- Registration Number
- NCT00098852
- Locations
- 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer
- Conditions
- Ovarian CancerLung CancerNeurotoxicity
- First Posted Date
- 2004-09-06
- Last Posted Date
- 2012-09-21
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 80
- Registration Number
- NCT00003072
- Locations
- 🇺🇸
Oncology Service of San Francisco General Hospital Medical Center, San Francisco, California, United States
🇺🇸UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States
🇺🇸UCSF/Mt. Zion Cancer Center, San Francisco, California, United States